Aller au contenu principal
  • Paul Scherrer Institut PSI
  • PSI Research, Labs & User Services

Digital User Office

  • Digital User Office
  • DE
  • EN
  • FR
Paul Scherrer Institut (PSI)
Rechercher
Paul Scherrer Institut (PSI)

Hauptnavigation

  • Research at PSIOuvrir ce point de menu principal
    • Research Initiatives
    • Research Integrity
    • Scientific Highlights
    • Scientific Events
    • Scientific Career
    • PSI-FELLOW
    • PSI Data Policy
  • Research Divisions and LabsOuvrir ce point de menu principal
    • Overview
    • Research with Neutrons and Muons
    • Photon Science
    • Energy and Environment
    • Nuclear Energy and Safety
    • Biology and Chemistry
    • Large Research Facilities
  • Facilities and InstrumentsOuvrir ce point de menu principal
    • Overview
    • Large Research Facilities
    • Facilities
    • PSI Facility Newsletter
  • PSI User ServicesOuvrir ce point de menu principal
    • User Office
    • Methods at the PSI User Facilities
    • Proposals for beam time
    • Proposal Deadlines
    • Data Analysis Service (PSD)
    • EU support programmes
  • DE
  • EN
  • FR

Digital User Office (mobile)

  • Digital User Office

Vous êtes ici:

  1. PSI Home
  2. Labs & User Services
  3. PSD
  4. COVID-19
  5. Research Areas
  6. MX Beamlines

Navigation secondaire

Photon Science Division

  • COVID-19 Sous-menu élargi
    • Publications
    • Rapid Access
    • COVID-19 Highlights
    • Research Areas Sous-menu élargi
      • MX Beamlines
      • X-ray Imaging for Biomedicine: Lung Imaging
      • Photonics for Biomedicine
      • Molecular Biology
      • Micro- and Nanofabrication for Biosensing
      • Testing of asymptomatic individuals for fast feedback-control of COVID-19 pandemics
      • Laboratory for Scientific Computing and Modelling COVID-19 questions
  • About PSD
    • Organisational Structure
    • Photon Science Advisory Committee
  • People
  • Laboratories
  • Facilities
  • Industrial Services
  • Projects
    • ERC Synergy project HERO: Hidden Entangled and Resonating Orders
    • SLS 2.0
  • European and International Collaborations
    • BEATS
    • CALIPSOplus
    • ExPaNDS
    • LEAPS
    • Lightsources
  • Scientific Highlights and News
  • Publications

Info message

Ce contenu n'est pas disponible en français.

MX Beamlines

The macromolecular crystallography (MX) group at the Swiss Light Source operates three beamlines (PXI, PXII and PXIII), which allow study of biological molecules such as proteins, viruses and nucleic acids (RNA and DNA). In the macromolecular crystallography experiment high intensity incident X-rays are diffracted on a crystalline sample giving rise to a regular pattern of sharp spots. Analysis of the intensities and positions of the diffraction spots allow determination of high-resolution three-dimensional arrangement of atoms in space (macromolecular structure). MX technique enables research, which aims at 1) understanding function and mechanism of macromolecules in cells and organisms; 2) structure-based drug design utilizing high-throughput screening (HTC) and/or fragment-based drug design (FBDD) approaches.

To aid academic and industrial drug design projects utilizing FBDD with X-ray crystallography (xFBDD) as primary technique, the SLS MX group has recently established the fast fragment and compound-screening (FFCS) pipeline. The goal of the FFCS project was to create an integrated next generation pipeline for high throughput crystal soaking, handling and data collection, which allows crystallography-based screening of protein crystals against hundreds of potential drug leads. The project created tools that make the process faster, more efficient, more automated and thereby more appealing to users. The resulting FFCS pipeline has been successfully applied to support analysis of small-molecule ligands of the human YTHDC1 domain that recognizes N6-methylated adenine (m6A) in RNA (1).

Coronaviruses are RNA viruses, which cause significant percentage of acute respiratory illnesses in humans (SARS, MERS & COVID-19 pandemics of deadly pneumonia). No vaccines or specific antiviral treatment are currently available against Coronaviruses. Structural characterization of proteins  essential in virus life cycle provides valid functional information and is the basis for structure-based drug design.

The SLS MX group at the Photon Science Division at PSI collaborates with various Chinese groups on the X-ray structure determination of viral proteins and their complexes with inhibitors. Currently research on coronaviruses is still relatively limited, despite three pandemic outbreaks within the last 15 years, i.e. 2003 SARS, 2012/2015 MERS, 2019/20 COVID-19. The development of the antiviral treatment is in (obvious) demand and presents a unique research opportunity. The MX beamlines and crystallization facility at PSI will provide priority access to COVID-19 related structures-based drug discovery projects.

Structural analysis of SARS-CoV-2 PLpro in complex with full length ISG15

First MX results of the priority COVID-19 call

Beamline X06SA-PXI

Scientists from the Goethe University in Frankfurt am Main, Germany have published results on the papain-like protease (PLpro), an essential enzyme of SARS-CoV-2. The structural biology work was performed at the macromolecular crystallography beamline X06SA-PXI at SLS following the opening of the "PRIORITY COVID-19 Call”. The paper was submitted within one month after answering the proposal call. The crystallographic data collection happened on the 9th of April after the planned Easter shutdown of the SLS was cancelled for this specific experiment.

For the full article, please click here

Two protein structures from coronavirus determined at PX beamline at SLS

The SLS MX group participated in the structural characterization of the MERS coronavirus nsp13 helicase, which is one of 3 evolutionary most conserved proteins in nidoviruses and a central component of virus replication-transcription complex ((2); Figure 1A). Moreover, structure of the human betacoronavirus HKU1 protein S1, which docks virus to the cells of infected person, was solved with experimental phasing technique called native-SAD using data collected at the SLS MX beamline X06DA ((3); Figure 1B)

Figure 1. Structures of the MERS coronavirus nsp13 helicase (a) and human betacoronavirus HKU1 protein S1 (b)
Figure 1. Structures of the MERS coronavirus nsp13 helicase (a) and human betacoronavirus HKU1 protein S1 (b)

Crystal structure of the NS3-like helicase from Alongshan virus

THe Alongshan virus (ALSV) is an emerging human pathogen recently identified in China and rapidly spreading to the European continent in 2019 raising concerns about public health. ALSV belongs to the distinct Jingmenvirus group within the Flaviviridae family. The X-ray structure, generated by the MX group at PSI, provides a structural framework for drug design and suggest a possibility of developing broad-spectrum antiviral drug against both Flavivirus and Jingmenvirus.

Alongshan3

Xiaopan Liu, Kaixiang Zhu, Justyna Aleksandra Wojdyla, Pu Chen, Bo Qin, Ziheng Li, Meitian Wang, and Sheng Cui, IUCr Journal, under revision

(1) Bedi RK, Huang D, Wiedmer L, Li Y, Dolbois A, Wojdyla JA, Sharpe ME, Caflisch A, Sledz P, 2020, Selectively Disrupting m6A-Dependent Protein-RNA Interactions with Fragments, ACS Chem Biol 15, 3, 618-625, https://doi.org/10.1021/acschembio.9b00894

(2) Hao W, Wojdyla JA, Zhao R, Han R, Das R, Zlatev I, Manoharan M, Wang M, Cui S, 2017, Crystal structure of Middle Eastrespiratory syndrome coronavirus helicase, PLoS Pathogens 26;13(6):e1006474,  https://doi.org/10.1371/journal.ppat.1006474

(3) Ou X, Guan H, Qin B, Mu Z, Wojdyla J, Wang M, Dominguez SR, Qian Z, Cui S, 2017, Crystal structure of the receptor binding domain of the spike glycoprotein of human betacoronavirus HKU1,  Nature Communications 8, 15216, https://doi.org/10.1038/ncomms15216

Sidebar

Contact

Photon Science Division
Paul Scherrer Institut
5232 Villigen-PSI
Switzerland

Head of MX and Group Leader (i.p.) MX Applications
Laboratory for Macromolecules and Bioimaging LSB
Dr Meitian Wang
+41 56 310 41 75
meitian.wang@psi.ch

top

Pied de page

Paul Scherrer Institut

Forschungsstrasse 111
5232 Villigen PSI
Suisse

Téléphone: +41 56 310 21 11
Téléfax: +41 56 310 21 99

Comment nous trouver 
Contact

Centre de visiteurs psi forum
Laboratoire élèves iLab (en allemand)
Centre de protonthérapie
Centre de Formation du PSI (en allemand)
PSI Guest House (en anglais)
PSI Gastronomie (en allemand)

Service & Support

  • Annuaire
  • User Office
  • Accelerator Status
  • Publications du PSI
  • Fournisseurs
  • E-facture
  • Computing (en anglais)
  • Sicherheit (en allemand)

Carrière

  • Travailler au PSI
  • Offres d'emploi
  • Formation initiale et formation continue
  • Formation professionnelle (en allemand)
  • Centre de Formation du PSI

Pour les médias

  • Le PSI en bref
  • Chiffres et faits
  • Le coin médias
  • Communiqués de presse
  • Social Media Newsroom

Suivez le PSI: Twitter (en allemand) LinkedIn Youtube Issuu RSS

Footer legal

  • Impressum
  • Conditions d'utilisation
  • Login éditeurs